With its current market cap plus a credible products plus strong finance backing plus exclusive right in the US plus......Its much more healthy than a lot of other Biotech stocks!
PEK Shenghe holds one-fifth of Peak Rare Earths, and using that weight, has scrapped a superior takeover offer